NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/06/2022
Voltar para busca
Dado oficial do USPTO
CYTOVALE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CYTOVALE
ST13
US500000088984241Classe
9, 10, 44
Pedido
88984241
Registro
6775529
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
28/06/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 10, 44
Data de depósito
05/06/2020
Data de registro
28/06/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/06/2022
Última transação
28/06/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
02/09/2014
Primeiro uso no comércio
02/09/2014
Código do desenho
4
Tipo de titular
03
Localização do titular
San Francisco, CA
Examinador
HOLTZ, ALLISON
Unidade examinadora
M20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Cytovale Inc.
Representantes
Holly Pranger PRANGER LAW PC
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
scientific instruments for biological testingbiological sample processingscientific researchlaboratory useautomated instruments in the nature of diagnostic apparatus for performing diagnostic assays and automated instruments in the nature of diagnostic apparatus for performing sample preparations; kits comprising scientific instrumentsautomated instruments in the nature of blood testing apparatus for performing diagnostic assays and automated instruments in the nature of automated blood testing apparatus for performing sample preparationsassays and reagents for biological testingfor biological sample processingall for scientific research and laboratory use
Classe 10
medical diagnostic instruments for the analysis of body fluids; medical testing kits for sepsis; blood testing apparatus; medical diagnostic apparatus for carrying-out diagnostic tests for medical purposesflow cytometry apparatus; apparatus for diagnostic purposesmedical diagnostic apparatus for testing for sepsis and for detecting sepsis; medical apparatuses for the examination and analysis of proteinspeptidesantibodies and molecules for medical diagnostic use and components therefor; diagnostic testing kits comprised of sample testing reagents or consumables for medical use consisting primarily of probesbuffers and reagents for use in microbial testing; medical devices for use in the treatment of sepsiscancer and other immune-mediated conditions in the fields of oncologyhematologyfor diagnosis and treatment of sepsis; automated medical instrumentshost-response testing equipmentcytometers which use electronics and optical fluorescence flow cytometry to analyze human cells; medical micro imaging apparatuses for molecular diagnostics and cytometry for medical diagnostic use and components therefor; digital imaging platformsmedical micro imaging apparatus for acquiring and processing microscopic images for medical diagnostic use; digital imaging platformsmedical micro imaging apparatus for use in the examination of cellsproteins and peptides for medical diagnostic use
Classe 44
medical testing and medical analysis for diagnostic or treatment purposes provided by medical laboratories; providing medical information; medical diagnostic testing services; oncologicalhematological and sepsis testing services for medical purposes; medical screening services; medical advisory services relating to disease including providing disease risk assessment and related information; comprehensive clinical laboratory medical testing servicesanatomic pathology testingflow cytometry testingmolecular based testingcytogenetics testingfluorescent in situ hybridization (fish) testing
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
28/06/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26/05/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
25/05/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
19/05/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
19/05/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/05/2022
IUAF
USE AMENDMENT FILED
09/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/05/2022
DRRR
DIVISIONAL REQUEST RECEIVED
02/05/2022
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/05/2022
EISU
TEAS STATEMENT OF USE RECEIVED
02/05/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/09/2021
PUBO
PUBLISHED FOR OPPOSITION
14/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/08/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
12/08/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/08/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/08/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/08/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
20/02/2021
GNFR
FINAL REFUSAL E-MAILED
20/02/2021
CNFR
FINAL REFUSAL WRITTEN
20/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/02/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
16/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/09/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/09/2020
GNRT
NON-FINAL ACTION E-MAILED
15/09/2020
CNRT
NON-FINAL ACTION WRITTEN
15/09/2020
DOCK
ASSIGNED TO EXAMINER
09/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/06/2020
NWAP
NEW APPLICATION ENTERED
09/06/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CYTOVALE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.